Concepedia

Author

Ben Van Camp

Vrije Universiteit Brussel

Also Known As

BEN VAN CAMP, BEN Van CAMP, Ben Van Camp, Ben van Camp, Guido Tricot, Karin Vanderkerken, Van Camp, B.

71

Publications

3.7K

Citations

31

H-Index

50

Concepts

All Affiliations

Vrije Universiteit BrusselUniversity of SheffieldUniversitair Ziekenhuis BrusselTianjin Medical University General HospitalUniversity of Antwerp
BV

About

Ben Van Camp is an author at Vrije Universiteit Brussel specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

1K

2

Cell Biology

12

13

857

3

Health Sciences

3

3

282

4

Engineering

1

1

59

5

Biomedical Engineering

1

1

59

Ben Van Camp

×

35

Publications

2.4K

Citations

26

H-Index

YearCitations

Zoledronic Acid Treatment of 5T2MM-Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival

Peter I. Croucher, Hendrik De Raeve, Mark Perry,

Journal of Bone and Mineral Research

2003

267

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.

Karin Vanderkerken, Evy De Leenheer, C M Shipman,

PubMed

2003

189

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug

Jinsong Hu, Damian Handisides, Els Van Valckenborgh,

Blood

2010

155

Evidence that the clonogenic cell in multiple myeloma originates from a pre‐switched but somatically mutated B cell

Marleen Bâkkus, Ivan Van Riet, Ben Van Camp,

British Journal of Haematology

1994

145

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

Eline Menu, Helena Jernberg‐Wiklund, Thomas Strömberg,

Blood

2005

144

Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model

Eline Menu, Evy De Leenheer, Hendrik De Raeve,

Clinical & Experimental Metastasis

2006

114

Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition

Jinsong Hu, Nana Dang, Eline Menu,

Blood

2011

104

Bone Marrow-Derived Mesenchymal Stromal Cells are Attracted by Multiple Myeloma Cell-Produced Chemokine CCL25 and Favor Myeloma Cell Growth in Vitro and In Vivo

Song Xu, Eline Menu, Ann De Becker,

Stem Cells

2011

104

Insulin-Like Growth Factor-1 Acts as a Chemoattractant Factor for 5T2 Multiple Myeloma Cells

Karin Vanderkerken, Kewal Asosingh, Filip Braet,

Blood

1999

91

Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of Myeloma

Sarah Deleu, Miguel Lemaire, Janine Arts,

Cancer Research

2009

90

Page 1